INVENTIV HEALTH INC
SymbolVTIV

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

inVentiv Health Reports Financial Results for Third Quarter 2009

2009-11-04 19:00 ET - News Release



 * Third Quarter Revenues declined 6% to $270.5 mm
 * Third Quarter Adjusted EPS $0.34 (GAAP EPS $0.35)
 * President/COO Resigns

SOMERSET, N.J., Nov. 4, 2009 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV), a leading provider of commercialization services to the global pharmaceutical and healthcare industries, today announced financial results for the third quarter 2009.

Third Quarter 2009 Results attributable to inVentiv Health, Inc.: 



 * Total revenues decreased 6% to $270.5 million for the third 
   quarter of 2009, compared to $289.2 million for the third quarter 
   of 2008.  Net revenues declined 4% to $232.8 million, compared to 
   $243.4 million for the third quarter of 2008.  

 * Adjusted EBITDA decreased 12% to $32.6 million for the third 
   quarter of 2009, compared to $37.2 million for the third quarter 
   of 2008.  Adjusted Operating income decreased 13% to $24.3 
   million for the third quarter of 2009, compared to $27.8 million 
   for the third quarter of 2008.  GAAP operating income was $24.6 
   million for the third quarter of 2009, compared to $27.6 million 
   for the third quarter of 2008.

 * Adjusted Net income attributable to inVentiv Health, Inc. was 
   $11.5 million for the third quarter of 2009, compared to 
   adjusted net income of $13.6 million for the third quarter of 
   2008.  Net income attributable to inVentiv Health, Inc., as 
   reported was $11.7 million for the third quarter of 2009, 
   compared to $13.3 million for the third quarter of 2008.

 * Adjusted diluted earnings per share (EPS) attributable to 
   inVentiv Health, Inc. was $0.34 for the third quarter of 2009
   and GAAP diluted EPS was $0.35, compared to an adjusted diluted 
   EPS of $0.41 for the third quarter of 2008 and GAAP diluted EPS 
   of $0.40 for the third quarter of 2008.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.